Clinical Research Directory
Browse clinical research sites, groups, and studies.
Novel Serum Markers for Monitoring Response to Anti-Cancer Therapy
Sponsor: Stanford University
Summary
The purpose of this study is to measure the levels of serum proteins and other biomarkers in cancer patients and in patients suspected of having cancer. We believe that some of these markers may be useful for confirming the diagnosis or for selecting patients for specific types of cancer therapies. These markers may also help to predict response to therapy, relapse after therapy, and survival after therapy.
Official title: Development of Novel Serum Markers for Monitoring Response to Anti-Cancer Therapy
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
2000
Start Date
2002-01
Completion Date
2032-01
Last Updated
2026-02-10
Healthy Volunteers
Yes
Interventions
blood draw
Locations (1)
Stanford University School of Medicine
Stanford, California, United States